William Tap
@WTapMD
Followers
2K
Following
2K
Media
30
Statuses
625
Chief, #Sarcoma Medical Oncology Service, MSKCC, building an #AYA program - advice welcome. #Equity and #CulturalCompetence in #Healthcare and life.
Manhattan, NY
Joined June 2018
RT @sandrapdangelo: Afamicel, TCR targeting MAGEA-4 approved for #synovial sarcoma. A remarkable advancement for our patients, laying the f….
businesswire.com
Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company working to redefine the treatment of solid tumor cancers with cell therapy, today announced U.S. Food ...
0
28
0
RT @sandrapdangelo: The registrational enabling Spearhead-1 study shows that afami-cel, an engineered T cell targeting MAGEA4, has promisin….
0
32
0
RT @pawel_sobczuk: Are you attending #ESMOSarcomaAndRareCancers24?.Don't miss our excelent Young Oncologists Sessions:.🔸Vesalius talk on ma….
0
10
0
RT @everettmoding: Thrilled to share our latest study in @NatureCancer investigating the diverse malignant and stromal cell states that mak….
nature.com
Nature Cancer - Subramanian et al. use the EcoTyper machine-learning framework to characterize the tumor, immune and stromal cell states and ecosystems that comprise sarcomas.
0
32
0
RT @MSKLibrary: Featured today by @MSKLibrary: A call to action to advance patient-focused and decentralized #clinicaltrials: https://t.co/….
acsjournals.onlinelibrary.wiley.com
This commentary is a call to action for a concerted commitment and effort to transform clinical trials and enable people with cancer to participate in clinical trials closer to home. Three key...
0
1
0
RT @MSKCancerCenter: We are pleased to welcome Dr. Damon Reed as the inaugural Head of the Division of Pediatric Solid Tumors and as Chief….
0
5
0
RT @YJanjigianMD: @MSKCancerCenter @MSK_DeptOfMed We are hiring a physician scientist w/ focus in GI Oncology.We value academic rigor, inno….
0
8
0
RT @MSKLibrary: Featured today by @MSKLibrary: A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma https://….
aacrjournals.org
AbstractPurpose:. Epacadostat, an indole 2,3 dioxygenase 1 (IDO1) inhibitor, proposed to shift the tumor microenvironment toward an immune-stimulated state, showed early promise in melanoma but has...
0
2
0
RT @EHEfoundation: The EHE Global Patient Registry is a powerful way for individuals with Epithelioid Hemangioendothelioma and their family….
0
8
0
RT @MSKCancerCenter: Congratulations to gastrointestinal oncologist Dr. @DebSchrag, who received the @ASCO-@AmericanCancer Society Cancer P….
0
10
0
RT @ctosociety: Introducing the brand new CTOS Podcast - Interview series, featuring David Thomas, FRACP, PhD. Hosted by Inga-Marie Schae….
0
11
0
RT @Winette_vdGraaf: Inspiring start of 3 days focussed on PROs. Today with a focus on #AYA cancer research & care. Important global perspe….
0
5
0
RT @GladdyLab: Abstract submission is open #ctos2023 Nov 1-4 2023 in Dublin,🇮🇪 .Sarcoma of the Year #SRBC .Keynote….
0
15
0
RT @pawel_sobczuk: 🚨Today 12.15 - Vesalius talk for young oncologists (and those who feel young) about career in rare cancers! Can’t miss i….
0
4
0
RT @MSKSarcoma: We are thrilled to welcome Dr. Bob Maki back to the MSK family. Dr. Maki brings long-standing expertise in #sarcoma through….
0
18
0
RT @ProfDMThomas: 1/1 Thanks to our global collaborators that made this paper possible: Heritable defects in telomere and mitotic function….
science.org
Human genome germline sequencing reveals that defects in centrosome and shelterin pathways may specifically increase risk for sarcomas.
0
29
0
RT @kencardonaMD: We are recruiting an experienced sarcoma medical oncologist to join and co-lead our sarcoma program at @WinshipAtEmory. T….
0
20
0